Cell type-specific binding patterns reveal that TCF7L2 can be tethered to the genome by association with GATA3
Ontology highlight
ABSTRACT: The TCF7L2 transcription factor is linked to a variety of human diseases, including type 2 diabetes and cancer. One mechanism by which TCF7L2 could influence expression of genes involved in diverse diseases is by binding to distinct regulatory regions in different tissues. To test this hypothesis, we performed ChIP-seq for TCF7L2 in 6 human cell lines. We identified 116,000 non-redundant TCF7L2 binding sites, with only 1,864 sites common to the 6 cell lines. Using ChIP-seq, we showed that many genomic regions that are marked by both H3K4me1 and H3K27Ac are also bound by TCF7L2, suggesting that TCF7L2 plays a critical role in enhancer activity. Bioinformatic analysis of the cell type-specific TCF7L2 binding sites revealed enrichment for multiple transcription factors, including HNF4alpha
ORGANISM(S): Homo sapiens
SUBMITTER: rui wang
PROVIDER: E-GEOD-38447 | biostudies-arrayexpress |
REPOSITORIES: biostudies-arrayexpress
ACCESS DATA